Primary Care Migraine© Diagnosis, Secondary Headache, Acute Therapy, Prevention

Primary Care Migraine© is a free web and app-based training program that provides primary care professionals with continuing medical education (CME) credits while learning about the most cutting-edge treatments and preventative protocols for migraine disease. This activity includes four video-based modules.


Primary Care Migraine© CME Modules

MODULE 1: The Diagnosis of Migraine in Primary Care
Learning Objectives
At the conclusion of this activity, participants should be able to:
  • Discuss the epidemiology of migraine both within the population, but also as it relates to patients seen in your primary care offices
  • Recognize the under-diagnosis of migraine
  • Apply the diagnostic criteria for migraine
  • Use abbreviated tools to help simplify the diagnosis of migraine in your practice
  • Develop a general approach to the diagnosis of migraine and other headache disorder

 MODULE 2: Secondary Headache Disorders in Primary Care
Learning Objectives
At the conclusion of this activity, participants should be able to:
  • Recognize the Red Flags that suggest a secondary headache disorder
  • Order the appropriate imaging test to help diagnose headache
  • Recommend a lumbar puncture when indicated by headache signs and symptoms and interpret findings

MODULE 3: ABCs of Acute Therapy in Primary Care
Learning Objectives
At the conclusion of this activity, participants should be able to:
  • Define acute medication use
  • Discuss their mechanisms of action
  • Set realistic goals for therapy
  • Discuss the different types of acute therapies
  • Review common side effects and cautions with their use

MODULE 4: ABCs of Preventive Therapy in Primary Care
Learning Objectives
At the conclusion of this activity, participants should be able to:
  • Define preventive therapy treatments for migraine
  • Review preventive treatment indications
  • Identify the medication classes used for migraine prevention

Acknowledgement of Commercial Support


This activity is supported by educational grants from Amgen, Biohaven Pharmaceuticals, and Lilly.